FASLG and neoplasm: This is due to the combined effects of: 1) the pro-inflammatory properties of FasL; 2) expression of a range of antigens by whole tumour cells; and 3) removal of the inhibitory influence of CD25+ cells on both innate and adaptive immune responses.